Company: G
Filing Date: 2025-04-09
Form Type: DEF 14A
Source: 0001140361-25-013031
Chunk: 23

Company: Genpact LTD
Filing Date: 2025-04-09
Form: DEF 14A
Chunk 23
---
5. |

| (18) | This amount includes 44,947 shares held directly by Mr. Madden and 10,539 vested RSUs, the shares underlying which will be issued on December 31, 2025. |

| (19) | This amount includes 46,228 shares held directly by Ms. Morken and 6,707 vested RSUs, the shares underlying which will be issued on December 31, 2025. |

| (20) | This amount includes 18,566 shares held directly by Mr. Stevens and 6,707 vested RSUs, the shares underlying which will be issued on December 31, 2025. |

| (21) | This amount includes options to purchase 2,133,106 shares that are exercisable within 60 days, 567,364 shares held directly by Mr. Tyagarajan, 5,300 shares held in trust for the benefit of Mr. Tyagarajan’s family members and 6,707 vested RSUs, the shares underlying which will be issued on December 31, 2025. |

| (22) | This amount includes 53,473 shares held directly by Mr. Verdi and 6,707 vested RSUs, the shares underlying which will be issued on December 31, 2025. |

Delinquent section 16(a) reports Section 16(a) of the Exchange Act requires our directors, executive officers and the holders of more than 10% of our common shares to file with the SEC initial reports of ownership of our common shares and other equity securities on a Form 3 and reports of changes in such ownership on a Form 4 or Form 5. Directors, executive officers and 10% shareholders are required by SEC regulations to furnish us with copies of all Section 16(a) forms they file. Based on our review of copies of reports filed with the SEC and except as set forth in the above table, we do not believe that there are currently any beneficial owners of more than ten percent of our common shares. Based solely on our review of copies of reports filed by our directors and executive officers with the SEC or written representations from such persons pursuant to Item 405 of Regulation S-K, we believe that during the fiscal year ended December 31, 2024, all filings required to be made by our directors and executive officers pursuant to Section 16(a) with respect to Genpact Limited securities were made in accordance with Section 16(a), except for